METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Clinical trials for METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough colon cancers: Two-Drug combo trial opens
Disease control Recruiting nowThis study is testing whether combining two immunotherapy drugs can help control advanced colon cancer that has stopped responding to standard chemotherapy. The trial will involve about 24 adults whose cancer has spread and who have already tried standard treatments. Researchers …
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Dan Feng • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New hope for Tough-to-Treat colon cancer patients
Disease control Recruiting nowThis early-stage trial is testing whether combining two cancer drugs—abemaciclib and 5-fluorouracil—is safe and tolerable for people with advanced colorectal cancer that has spread and stopped responding to standard treatments. Researchers will enroll 39 adults to find the best d…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Scientists test new drug duo to attack advanced cancers
Disease control Recruiting nowThis early-phase trial is testing a new combination of two drugs, temozolomide and M1774, for people with advanced cancers that have spread. The main goals are to find the safest and most effective dose and to see if the combination can shrink or stabilize tumors, especially in a…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Feb 25, 2026 15:07 UTC